Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
Elaine Chiquette,1 Elif A Oral,2 Abhimanyu Garg,3 David Araújo-Vilar,4 Praveen Dhankhar5 1Aegerion Pharmaceuticals, Cambridge, MA, USA; 2Brehm Center for Diabetes Research and Metabolism, Endocrinology and Diabetes Division, Department of Internal Medicine, University of Michigan, Ann Arb...
Main Authors: | Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/estimating-the-prevalence-of-generalized-and-partial-lipodystrophy-fin-peer-reviewed-article-DMSO |
Similar Items
-
A serendipitous discovery: an adult case of congenital generalized lipodystrophy
by: Abdul Rehman Zia Zaidi, et al.
Published: (2020-03-01) -
Visceral fat does not contribute to metabolic disease in lipodystrophy
by: N. Malandrino, et al.
Published: (2019-02-01) -
European lipodystrophy registry: background and structure
by: Julia von Schnurbein, et al.
Published: (2020-01-01) -
Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
by: Vaia Lambadiari, et al.
Published: (2021-06-01) -
Lipodystrophy as a Late Effect after Stem Cell Transplantation
by: Daniel Tews, et al.
Published: (2021-04-01)